152 related articles for article (PubMed ID: 31692672)
1. The Effects of Administration of Vitamin D, Infliximab, and Leflunomide on Testosterone Concentrations in Rats under Atorvastatin Therapy.
Aykan DA; Seyithanoglu M
Eurasian J Med; 2019 Oct; 51(3):224-227. PubMed ID: 31692672
[TBL] [Abstract][Full Text] [Related]
2. Effects of atorvastatin on the Th1/Th2 polarization of ongoing experimental autoimmune myocarditis in Lewis rats.
Liu W; Li WM; Gao C; Sun NL
J Autoimmun; 2005 Dec; 25(4):258-63. PubMed ID: 16242301
[TBL] [Abstract][Full Text] [Related]
3. High doses of atorvastatin and simvastatin induce key enzymes involved in VLDL production.
Roglans N; Verd JC; Peris C; Alegret M; Vázquez M; Adzet T; Díaz C; Hernández G; Laguna JC; Sánchez RM
Lipids; 2002 May; 37(5):445-54. PubMed ID: 12056585
[TBL] [Abstract][Full Text] [Related]
4. Atorvastatin and simvastatin have distinct effects on hydroxy methylglutaryl-CoA reductase activity and mRNA abundance in the guinea pig.
Conde K; Roy S; Freake HC; Newton RS; Fernandez ML
Lipids; 1999 Dec; 34(12):1327-32. PubMed ID: 10652993
[TBL] [Abstract][Full Text] [Related]
5. Atorvastatin Improves Hepatic Lipid Metabolism and Protects Renal Damage in Adenine-Induced Chronic Kidney Disease in Sprague-Dawley Rats.
Ghelani H; Razmovski-Naumovski V; Inampudi V; Chang D; Nammi S
Biomed Res Int; 2019; 2019():8714363. PubMed ID: 31828139
[TBL] [Abstract][Full Text] [Related]
6. Atorvastatin in the treatment of primary hypercholesterolemia and mixed dyslipidemias.
Yee HS; Fong NT
Ann Pharmacother; 1998 Oct; 32(10):1030-43. PubMed ID: 9793596
[TBL] [Abstract][Full Text] [Related]
7. Neuroprotective potential of atorvastatin and simvastatin (HMG-CoA reductase inhibitors) against 6-hydroxydopamine (6-OHDA) induced Parkinson-like symptoms.
Kumar A; Sharma N; Gupta A; Kalonia H; Mishra J
Brain Res; 2012 Aug; 1471():13-22. PubMed ID: 22789904
[TBL] [Abstract][Full Text] [Related]
8. HMG-CoA reductase inhibitor rosuvastatin improves abnormal brain electrical activity via mechanisms involving eNOS.
Seker FB; Kilic U; Caglayan B; Ethemoglu MS; Caglayan AB; Ekimci N; Demirci S; Dogan A; Oztezcan S; Sahin F; Yilmaz B; Kilic E
Neuroscience; 2015 Jan; 284():349-359. PubMed ID: 25453767
[TBL] [Abstract][Full Text] [Related]
9. Differential effects of atorvastatin treatment and withdrawal on pentylenetetrazol-induced seizures.
Funck VR; de Oliveira CV; Pereira LM; Rambo LM; Ribeiro LR; Royes LF; Ferreira J; Guerra GP; Furian AF; Oliveira MS; Mallmann CA; de Mello CF; Oliveira MS
Epilepsia; 2011 Nov; 52(11):2094-104. PubMed ID: 21906051
[TBL] [Abstract][Full Text] [Related]
10. Effects of long-term administration of HMG-CoA reductase inhibitor, atorvastatin, on stroke events and local cerebral blood flow in stroke-prone spontaneously hypertensive rats.
Tanaka N; Katayama Y; Katsumata T; Otori T; Nishiyama Y
Brain Res; 2007 Sep; 1169():125-32. PubMed ID: 17706949
[TBL] [Abstract][Full Text] [Related]
11. Rechallenging Statin Therapy in Veterans With Statin-Induced Myopathy Post Vitamin D Replenishment.
Kang JH; Nguyen QN; Mutka J; Le QA
J Pharm Pract; 2017 Oct; 30(5):521-527. PubMed ID: 27798247
[TBL] [Abstract][Full Text] [Related]
12. Atorvastatin: pharmacological characteristics and lipid-lowering effects.
Poli A
Drugs; 2007; 67 Suppl 1():3-15. PubMed ID: 17910517
[TBL] [Abstract][Full Text] [Related]
13. The effect of atorvastatin on cardiometabolic risk factors in women with non-classic congenital adrenal hyperplasia: A pilot study.
Krysiak R; Kowalcze K; Bednarska-Czerwińska A; Okopień B
Pharmacol Rep; 2019 Jun; 71(3):417-421. PubMed ID: 31003151
[TBL] [Abstract][Full Text] [Related]
14. Tissue-specific effects of atorvastatin on 3-hydroxy-3-methylglutarylcoenzyme A reductase expression and activity in spontaneously hypertensive rats.
Chen GP; Yao L; Lu X; Li L; Hu SJ
Acta Pharmacol Sin; 2008 Oct; 29(10):1181-6. PubMed ID: 18817622
[TBL] [Abstract][Full Text] [Related]
15. Atorvastatin treatment does not affect gonadal and adrenal hormones in type 2 diabetes patients with mild to moderate hypercholesterolemia.
Santini SA; Carrozza C; Lulli P; Zuppi C; CarloTonolo G; Musumeci S
J Atheroscler Thromb; 2003; 10(3):160-4. PubMed ID: 14564085
[TBL] [Abstract][Full Text] [Related]
16. Treatment of experimental autoimmune uveoretinitis with atorvastatin and lovastatin.
Kohno H; Sakai T; Saito S; Okano K; Kitahara K
Exp Eye Res; 2007 Mar; 84(3):569-76. PubMed ID: 17208229
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of HMG-CoA reductase by atorvastatin decreases both VLDL and LDL apolipoprotein B production in miniature pigs.
Burnett JR; Wilcox LJ; Telford DE; Kleinstiver SJ; Barrett PH; Newton RS; Huff MW
Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):2589-600. PubMed ID: 9409231
[TBL] [Abstract][Full Text] [Related]
18. Vitamin D3 effects on lipids differ in statin and non-statin-treated humans: superiority of free 25-OH D levels in detecting relationships.
Kane L; Moore K; Lütjohann D; Bikle D; Schwartz JB
J Clin Endocrinol Metab; 2013 Nov; 98(11):4400-9. PubMed ID: 24030939
[TBL] [Abstract][Full Text] [Related]
19. Pre- and postnatal toxicity of the HMG-CoA reductase inhibitor atorvastatin in rats.
Henck JW; Craft WR; Black A; Colgin J; Anderson JA
Toxicol Sci; 1998 Jan; 41(1):88-99. PubMed ID: 9520344
[TBL] [Abstract][Full Text] [Related]
20. Atorvastatin: an updated review of its pharmacological properties and use in dyslipidaemia.
Malhotra HS; Goa KL
Drugs; 2001; 61(12):1835-81. PubMed ID: 11693468
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
